Home › NDC Lookup › Ingredients › Famotidine › 68001-0494-06
Famotidine 10 mg Tablet, 60-count — NDC 68001-0494-06 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Famotidine 10 mg Tablet, 60-count — NDC 68001-494-06 (Billing 68001-0494-06)

by BluePoint Laboratories · 1 BOTTLE in 1 CARTON / 60 TABLET in 1 BOTTLE

This is a package of 60 tablets of Famotidine 10 mg Tablet from BluePoint Laboratories, marketed since Apr 2021 and currently FDA-listed; retail pharmacies pay about $0.0947 per tablet (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 68001-0494-06
🏷️ FDA NDC (as labeled) 68001-494-06 billing pads the product segment with a zero
This package
Contains60-count Cost per ea$0.0947 NADAC Per package$5.68 / 60 tablets Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.2385/unit — full pricing hub ↓
Main listing for product 68001-494 · Also comes in: 30 tablets 68001-494-04
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 68001-494-06 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
68001 labeler · 494 product · 06 package
Package marketed since
Jun 17, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
60 EA per package
Barcode (UPC)
0368001494045
Medicaid fills, this package
7,045 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Famotidine (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Aug 6, 2026 — CGMP Deviations (Baxter Healthcare Corporation) · FDA recall D-0809-2026
Class I · Nov 6, 2025 — Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. (Fresenius Kabi USA, LLC) · FDA recall D-0182-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68001-494-06
Product NDC 68001-494
11-digit billing NDC 68001049406
NCPDP billing unit EA — each (per item)
RxCUI 199047
UNII 5QZO15J2Z8
UPC 0368001494045
Application # ANDA206531
SPL Set ID befd8d44-c6f7-eca2-e053-2995a90a714b
Established class (EPC) Histamine-2 Receptor Antagonist
Mechanism of action Histamine H2 Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-04-07
Route ORAL
Dosage form TABLET
Substance FAMOTIDINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 49200030000310
GPI class Famotidine
GCN Seq No 021688
GCN 46432
HICL code 004521
Ingredient (HICL) Famotidine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2D
Therapeutic class — specific (HIC3) Histamine H2-Receptor Inhibitors
AHFS code 04:92.00.00
AHFS class Other Antihistamines
FDB label name FAMOTIDINE 10 MG TABLET
FDB brand name Famotidine
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 021688
  • GCN: 46432
  • GPI-14 (Medi-Span): 49200030000310
  • HICL (First Databank): 004521
  • AHFS class code: 04:92.00.00
  • RxCUI (RxNorm): 199047
Why two NDCs? The FDA registers this code as 68001-494-06 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68001-0494-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-2 Receptor Antagonist class.

Pharmacologic class Histamine-2 Receptor Antagonist
Drug family (ATC) H2-receptor antagonists
How it works Histamine H2 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FAMOTIDINE 10 MG TABLET Ingredient Famotidine
📖 What it is MedlinePlus · NLM

Prescription famotidine is used to treat ulcers (sores on the lining of the stomach or small intestine); gastroesophageal reflux disease (GERD, a condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus [tube that connects the mouth and stomach]); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome (tumors in the pancreas or small intestine that cause increased production of stomach acid). Over-the-counter famotidine is used to prevent and treat heartburn due to acid indigestion and sour stomach caused by eat...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It reduces stomach acid. Over-the-counter versions relieve and prevent heartburn from acid indigestion and sour stomach. Prescription versions treat ulcers, GERD and erosive esopha...
  • With the over-the-counter tablets, swallow one with water and do not chew it. To prevent heartburn, take it shortly before a food or drink that triggers it. Do not take more than 2...
  • Headache, dizziness, constipation and diarrhea are the most common, and they are usually mild. Call your doctor if you have confusion, hallucinations, seizures, a rash with swellin...
  • Not always. Famotidine can lower absorption of some drugs that need stomach acid and can raise tizanidine levels. Tell me or your doctor everything you take before you start.
📖 Read our full Famotidine guide →
6
Nutrient depletion considerations

Famotidine may be associated with lower levels of 6 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.095 $5.68 / 60 tablets
Medicaid paysCMS SDUD · 12 mo $0.2385 $14.31 / 60 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Mar 2022 Oct 2022 Feb 2026 Sep 2026 $0.109 $0.092
▼ Down 5% over the last 22 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
68001-0494-04 68001-494-04 1 BOTTLE in 1 CARTON / 30 TABLET in 1 BOTTLE $0.0947 / ea $2.84 2021-04-07 — Active
68001-0494-06 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 60 TABLET in 1 BOTTLE $0.0947 / ea $5.68 2021-06-17 — Active

This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.0947 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 67% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 60-count package — 1 bottle in 1 carton / 60 tablet in 1 bottle.
How does this package differ from NDC 68001-0494-04?
Both are Famotidine 10 mg Tablet — the drug itself is identical. This page's package is the 60-count one, while NDC 68001-0494-04 is the 30 tablets package.
What NDC number is used to bill for this package of Famotidine 10 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Famotidine 10 mg 70000-0048-01 LEADER/ 30 tablets $0.092 — FDA listed save 3%
good sense acid reducer 10 mg 00113-0141-65 L. 1 tablet $0.095 — Availability likely —
heartburn relief original strength 10 mg 00904-5529-52 Major 60 tablets $0.095 — Availability likely —
Famotidine 10 mg 46122-0735-65 Amerisource 30 tablets $0.095 — Availability likely —
Famotidine 10 mgthis 68001-0494-06 BluePoint 60 tablets $0.095 — Availability likely —
famotidine 10 mg 69230-0326-01 Camber 100 tablets $0.095 — Availability likely —
foster and thrive acid reducer 10 mg 70677-1102-01 Strategic 1 tablet $0.095 — Availability likely —
famotidine 10 mg 83324-0003-30 CHAIN 30 tablets $0.096 — Availability likely +1%
Acid Controller Original Strength 10 mg 00363-0141-65 Walgreen 1 tablet — — Discontinued —
Famotidine 10 mg 00363-4400-19 WALGREEN 90 tablets — — FDA listed —
Famotidine 10 mg 00363-9607-09 WALGREEN 30 tablets — — FDA listed —
acid relief 10 mg 11822-6141-00 Rite 1 tablet — — Discontinued —
Pepcid AC Original Strength 10 mg 16837-0872-10 Kenvue 10 tablets — — Discontinued —
Famotidine 10 mg 21130-0022-30 Albertsons 30 tablets — — FDA listed —
Famotidine 10 mg 21130-0039-09 Better 30 tablets — — FDA listed —
signature care acid controller 10 mg 21130-0249-65 Safeway 1 tablet — — Discontinued —
Acid Controller 10 mg 21130-0771-75 Safeway 90 tablets — — FDA listed —
Famotidine 10 mg 25000-0086-03 MARKSANS 30 tablets — — FDA listed —
TopCare Acid Reducer 10 mg 36800-0141-65 Topco 1 tablet — — FDA listed —
acid controller 10 mg 37808-0301-65 H 1 tablet — — FDA listed —
Famotidine 10 mg 37835-0161-50 Bi-Mart 50 tablets — — FDA listed —
equaline heartburn prevention 10 mg 41163-0313-65 United 1 tablet — — FDA listed —
Original strength heartburn prevention 10 mg 41226-0719-06 KROGER 30 tablets — — FDA listed —
heartburn relief 10 mg 41250-0493-65 Meijer 1 tablet — — FDA listed —
CareOne Acid Relief 10 mg 41520-0901-65 American 1 tablet — — Discontinued —
acid reducer original strength 10 mg 42507-0141-75 HyVee 90 tablets — — FDA listed —
Acid Reducer Original Strength 10 mg 43598-0824-18 Dr.Reddys 180 tablets — — FDA listed —
Famotidine 10 mg 43602-0511-03 Ascent 300 tablets — — FDA listed —
Equate Famotidine 10 mg 49035-0507-75 Wal-Mart 90 tablets — — FDA listed —
Famotidine 10 mg 49035-0589-19 Wal-Mart 90 tablets — — FDA listed —
Famotidine 10 mg 53943-0100-30 Discount 30 tablets — — FDA listed —
Famotidine 10 mg 54257-0180-07 Magno-Humphries, 90 tablets — — FDA listed —
Famotidine 10 mg 55111-0118-04 Dr. 120 tablets — — FDA listed —
Famotidine 10 mg 55319-0408-01 FAMILY 60 tablets — — FDA listed —
Famotidine 10 mg 55319-0426-60 Family 60 tablets — — FDA listed —
Famotidine 10 mg 55681-0343-03 TWIN 300 tablets — — FDA listed —
dg health heartburn prevention original strength 10 mg 55910-0141-60 Dolgencorp, 1 tablet — — FDA listed —
acid reducer 10 mg 56062-0141-65 Publix 1 tablet — — FDA listed —
Famotidine 10 mg 57896-0317-03 GERI-CARE 30 tablets — — FDA listed —
Famotidine 10 mg 58602-0705-09 Aurohealth 10 tablets — — FDA listed —
Famotidine 10 mg 58602-0828-19 Aurohealth 90 tablets — — FDA listed —
acid controller original strength 10 mg 59779-0141-39 CVS 30 tablets — — FDA listed —
heartburn relief original strength 10 mg 63187-0999-10 Proficient 10 tablets — — FDA listed —
Famotidine 10 mg 63868-0583-30 Chain 30 tablets — — FDA listed —
Famotidine 10 mg 63941-0009-09 Best 30 tablets — — FDA listed —
Famotidine 10 mg 68016-0800-30 Chain 30 tablets — — FDA listed —
Famotidine 10 mg 69256-0002-47 HARRIS 30 tablets — — FDA listed —
Famotidine 10 mg 69842-0063-19 CVS 90 tablets — — FDA listed —
Famotidine 10 mg 69842-0928-84 CVS 30 tablets — — FDA listed —
Famotidine 10 mg 71205-0637-30 Proficient 30 tablets — — FDA listed —
Famotidine 10 mg 71821-0012-08 VKT 288461 tablets — — FDA listed —
basic care acid reducer 10 mg 72288-0141-65 Amazon.com 1 tablet — — FDA listed —
Famotidine 10 mg/10mg 72559-0038-23 Little 300 mg — — FDA listed —
Famotidine 10 mg 72657-0112-20 GLENMARK 200 tablets — — FDA listed —
Welmate Famotidine 10mg 10 mg 73581-0108-09 YYBA 90 tablets — — FDA listed —
Heartburn Relief 10 mg 83059-0005-05 Shield 50 tablets — — FDA listed —
Heartburn Relief 10 mg 83059-0031-05 Shield 50 tablets — — FDA listed —
Famotidine 10 mg 83324-0139-30 Chain 30 tablets — — FDA listed —
Acid Reducer 10 mg 51316-0816-39 CVS 30 tablets — — FDA listed —
Acid Reducer 10 mg 72288-0756-75 Amazon.com 90 tablets — — FDA listed —
Heartburn Relief 10 mg 83059-0185-01 Shield 15 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Apr 2021
📍
2026
Currently FDA-listed
5 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color pink
ShapeRound
ImprintCC;58
Size5 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Famotidine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII R12CBM0EIZ
    A natural wax derived from a Brazilian palm tree, used as a coating and polish on tablets and capsules. It creates a smooth, shiny finish that protects the medicine and improves appearance.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII RFW2ET671P
    Hydroxypropyl cellulose is a plant-derived thickening agent made from cellulose. It acts as a binder to hold tablet ingredients together and as a film-former to coat tablets or control how fast the medicine releases.
  • UNII R75537T0T4
    Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII AG9B65PV6B
    A starch derivative made from corn that helps tablets and capsules break apart quickly when swallowed. It acts as a disintegrant, allowing the medicine to dissolve and be absorbed in your stomach and intestines.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarnauba wax, corn starch, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, red iron oxide, sodium starch glycolate, talc and titanium dioxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBluePoint Laboratories
Application holderAUROBINDO PHARMA LTD
FDA applicationANDA206531 (ANDA)
Labeler code68001
First marketedApr 2021
Product typeHuman Otc Drug
Portfolio347 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 29 words ▾

Uses relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

⏱️ Dosage and Administration 67 words ▾

Directions adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. to prevent symptoms, swallow 1 tablet with a glass of water at any time from 15 to 60 minutes before eating food or drinking beverages that cause heartburn do not use more than 2 tablets in 24 hours children under 12 years: ask a doctor

⚠️ Warnings 16 words ▾

Warnings Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

📦 Storage and Handling 27 words ▾

Other Information read the directions and warnings before use keep the carton. It contains important information. store at 20° to 25°C (68° to 77°F) protect from moisture

🧪 Active Ingredient 9 words ▾

Active Ingredient in (Each Tablet) Famotidine USP 10 mg

🧪 Inactive Ingredients 23 words ▾

Inactive Ingredients carnauba wax, corn starch, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, red iron oxide, sodium starch glycolate, talc and titanium dioxide.

🎯 Purpose 3 words ▾

Purpose Acid reducer

📄 Do Not Use 33 words ▾

Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.These may be signs of a serious condition. See your doctor. with other acid reducers

📄 Ask a Doctor Before Use If 66 words ▾

Ask a Doctor Before Use if You Have had heartburn over 3 months. This may be a sign of a more serious condition. heartburn with lightheadedness, sweating, or dizziness chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness frequent chest pain frequent wheezing, particularly with heartburn unexplained weight loss nausea or vomiting stomach pain kidney disease

📄 Ask a Doctor or Pharmacist Before Use If 22 words ▾

Ask a Doctor or Pharmacist Before Use if You Are taking a prescription drug. Acid reducers may interact with certain prescription drugs.

📄 Stop Use and Ask a Doctor If 23 words ▾

Stop Use and ask a Doctor if your heartburn continues or worsens you need to take this product for more than 14 days

🤰 If Pregnant or Breast-Feeding 10 words ▾

If Pregnant or Breast-Feeding ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away

📄 Questions or Comments 124 words ▾

Questions or Comments? call 1-855-274-4122 Tips for Managing Heartburn Do not lie flat or bend over after eating Do not wear tight-fitting clothing around the stomach Do not eat before bedtime Raise the head of your bed Avoid heartburn-causing foods such as rich, spicy, fatty or fried foods, chocolate, caffeine, alcohol, and certain fruits and vegetables Eat slowly and avoid big meals If overweight, lose weight Quit smoking JUST ONE TABLET prevents and relieves heartburn due to acid indigestion brought on by eating and drinking certain foods and beverages.

Do not use if carton is open or if printed foil seal under bottle cap is open or torn. Manufactured by: Aurobindo Pharma Limited Unit-VII (SEZ), Mahabubnagar (Dt)-509302, India . For BluePoint Laboratories Rev: 02/2023

📄 Package Label / Principal Display Panel 40 words ▾

Package Label - Principal Display Panel Aurobindo Pharma Limited. NDC: 68001-494-04 Famotidine Tablets USP 10mg 30s Label Aurobindo Pharma Limited. NDC: 68001-494-04 Famotidine Tablets USP 10mg 30s Carton Famotidine Tabs USP 10mg 30s Labels Famotidine Tabs USP 10mg 30s Cartons

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
7K
Units reimbursed last 4 qtrs
311.9K
Gross reimbursed last 4 qtrs
$74.4K
Avg / prescription
$10.56
Avg / unit
$0.2385
Latest quarter Q1 2026
1.9KRx
Medicaid pays / ea
$0.2385
gross reimbursed
vs
NADAC / ea
$0.0947
acquisition cost
=
Spread
+$0.1438
+152% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
54% FFS 46% MCO
Fee-for-service · 3,779 Rx Managed care · 3,266 Rx
State Medicaid map
Alaska: no data reported AK Maine: 6,741 units · 483 per 100k residents ME Washington: 10,891 units · 139 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 7,658 units · 133 per 100k residents MN Wisconsin: no data reported WI Michigan: 15,460 units · 154 per 100k residents MI New York: 27,673 units · 141 per 100k residents NY Vermont: no data reported VT New Hampshire: 2,704 units · 193 per 100k residents NH Oregon: 5,333 units · 126 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 3,091 units · 24.6 per 100k residents IL Indiana: 13,608 units · 198 per 100k residents IN Ohio: 12,833 units · 109 per 100k residents OH Pennsylvania: 37,209 units · 287 per 100k residents PA New Jersey: 2,946 units · 31.7 per 100k residents NJ Massachusetts: 21,541 units · 308 per 100k residents MA California: 54,809 units · 141 per 100k residents CA Utah: 2,178 units · 63.7 per 100k residents UT Colorado: no data reported CO Nebraska: 9,036 units · 457 per 100k residents NE Missouri: no data reported MO Kentucky: 35,627 units · 787 per 100k residents KY West Virginia: no data reported WV Virginia: 11,352 units · 130 per 100k residents VA Maryland: 813 units · 13.2 per 100k residents MD Connecticut: 2,026 units · 56.0 per 100k residents CT Rhode Island: no data reported RI Arizona: 584 units · 7.9 per 100k residents AZ New Mexico: 340 units · 16.1 per 100k residents NM Kansas: 2,386 units · 81.2 per 100k residents KS Arkansas: 8,265 units · 269 per 100k residents AR Tennessee: 4,051 units · 56.8 per 100k residents TN North Carolina: no data reported NC South Carolina: 510 units · 9.5 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 5,680 units · 51.5 per 100k residents GA D.C.: no data reported DC Hawaii: 2,700 units · 188 per 100k residents HI Texas: 3,838 units · 12.6 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
7.9787
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 787 /100k
2 Maine 483 /100k
3 Nebraska 457 /100k
4 Massachusetts 308 /100k
5 Pennsylvania 287 /100k
6 Arkansas 269 /100k
7 Indiana 198 /100k
8 New Hampshire 193 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
60 tablets this page68001-0494-06 7,045 Rx · $74,394
30 tablets68001-0494-04 3,495 Rx · $36,737
Drug total (last 4 qtrs): 10,540 Rx · 464,766 units · $111,131 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Famotidine — the program that covers self-administered drugs. 29 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Famotidine. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$40.22M
Claims incl. refills
3.8M
Beneficiaries
2.6M
Spend / beneficiary
$15.35
Spend / claim
$10.62
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.